Apolipoprotein e and depressive symptoms: Shared or independent routes to age-related cognitive decline?

Psychosomatic Medicine

Volumn 76, Issue 2, 2014, Pages 98-100

  Luciano, Michelle ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

cognitive aging; depression; elderly; gene environment interaction

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ATTENTION; CLASSIFICATION; COGNITIVE DEFECT; COGNITIVE RESERVE; DEPRESSION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; HUMAN RELATION; LIFE HISTORY; LONGITUDINAL STUDY; MEMORY DISORDER; MOTIVATION; NEUROIMAGING; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

COGNITIVE AGING; DEPRESSION; ELDERLY; GENE-ENVIRONMENT INTERACTION;

AGING; APOLIPOPROTEINS E; DEPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MILD COGNITIVE IMPAIRMENT; RISK FACTORS;

EID: 84894437255     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000030     Document Type: Review

References (25)

1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23.
2. Davies G, Harris SE, Reynolds CA, Payton A, Knight HM, Liewald DC, Lopez LM, LucianoM, Gow AJ, Corley J, Henderson R, Murray C, Pattie A, FoxHC, Redmond P, LutzMW, Chiba-FalekO, Linnertz C, Saith S,Haggarty P, McNeill G, Ke X, OllierW, Horan M, Roses AD, Ponting CP, Porteous DJ, Tenesa A, Pickles A, Starr JM, Whalley LJ, Pedersen NL, Pendleton N, Visscher PM, Deary IJ. A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing. Mol Psychiatry 2014; 19:76-87.
3. De Jager PL, Shulman JM, Chibnik LB, Keenan BT, Raj T,Wilson RS, Yu L, Leurgans SE, Tran D, Aubin C, Anderson CD, Biffi A, Corneveaux JJ, Huentelman MJ, Rosand J, Daly MJ, Myers AJ, Reiman EM, Bennett DA, Evans DA. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging 2012;33:1017 e1-15.
4. Ganguli M, Du Y, Dodge HH, Ratcliff GG, Chang CC. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry 2006;63:153-60.
5. Schweitzer I, Tuckwell V, O'Brien J, Ames D. Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry 2002;17:997-1005.
6. Rajan KB,Wilson RS, Skarupsk KA, Mendes de Leon C, Evans DA. Gene behavior interaction of depressive symptoms and apolipoprotein E D4 allele on cognitive decline. Psychosom Med 2014;76.
7. Rigaud AS, Traykov L, Caputo L, Coste J, Latour F, Couderc R, Moulin F, Boller F, Forette F. Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology 2001;20:268-72.
8. Slifer MA, Martin ER, Gilbert JR, Haines JL, Pericak-Vance MA. Resolving the relationship between apolipoproteinE and depression. Neurosci Lett 2009;455:116-9.
9. Corsentino EA, Sawyer K, Sachs-Ericsson N, Blazer DG. Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychiatry 2009;17:155-65.
10. Niti M, Yap KB, Kua EH, Ng TP. APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies. J Gerontol A Biol Sci Med Sci 2009;64:306-11.
11. Yen YC, Rebok GW, Yang MJ, Lung FW. A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in latelife moderated by the environment. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:479-86.
12. Dean K, Oulhaj A, Zamboni G, Dejager CA, Wilcock GK. Role of depression in predicting time to conversion to mild cognitive impairment. Am J Geriatr Psychiatry 2013;pii:S1064-7481(12)00135-2. doi: 10.1016/ j.jagp.2012.12.025.
13. Surtees PG, Wainwright NW, Bowman R, Luben RN, Wareham NJ, Khaw KT, Bingham SA. No association between APOE and major depressive disorder in a community sample of 17,507 adults. J Psychiatr Res 2009; 43:843-7.
14. Class CA, Unverzagt FW, Gao S, Sahota A, Hall KS, Hendrie HC. The association between Apo E genotype and depressive symptoms in elderly African-American subjects. Am J Geriatr Psychiatry 1997;5:339-43.
15. Mauricio M, O'Hara R, Yesavage JA, Friedman L, Kraemer HC, Van De Water M, Murphy GM Jr. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry 2000;8:196-200.
16. Kita Y, Baba H, Maeshima H, Nakano Y, Suzuki T, Arai H. Serum amyloid beta protein in young and elderly depression: a pilot study. Psychogeriatrics 2009;9:180-5.
17. Pomara N, Bruno D, Sarreal AS, Hernando RT, Nierenberg J, Petkova E, Sidtis JJ, Wisniewski TM, Mehta PD, Pratico D, Zetterberg H, Blennow K. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry 2012;169:523-30.
18. Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ. Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry 2008;65:542-50.
19. Andreasen N, Blennow K. Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Peptides 2002;23:1205-14.
20. Metti AL, Cauley JA, Newman AB, Ayonayon HN, Barry LC, Kuller LM, Satterfield S, Simonsick EM, Yaffe K. Plasma beta amyloid level and depression in older adults. J Gerontol A Biol Sci Med Sci 2013;68:74-9.
21. Yaffe K, Weston A, Graff-Radford NR, Satterfield S, Simonsick EM, Younkin SG, Younkin LH, Kuller L, Ayonayon HN, Ding J, Harris TB. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 2011;305:261-6.
22. Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. APOE modifies the association between Abeta load and cognition in cognitively normal older adults. Neurology. 2012;78:232-40.
23. Butters MA, Klunk WE, Mathis CA, Price JC, Ziolko SK, Hoge JA, Tsopelas ND, Lopresti BJ, Reynolds CF 3rd, DeKosky ST, Meltzer CC. Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 2008;22:261-8.
24. Sachs-Ericsson N, Sawyer K, Corsentino E, Collins N, Steffans DC. The moderating effect of the APOE ?4 allele on the relationship between hippocampal volume and cognitive decline in older depressed patients. Am J Geriatr Psychiatry 2011;19:23-32.
25. Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004;19:592-600.